Michael Iskra Named CEO of Cleveland Diagnostics After FDA Approval
Iskra brings decades of commercialization expertise with leading global healthcare organizations Cleveland Diagnostics, Inc., a commercial-stage precision oncology company, has appointed Michael Iskra as its new Chief Executive Officer. Iskra...